Analysis of risk factors for carbohydrate metabolism disorders in the population of the Tyumen region
https://doi.org/10.47093/2713-069X.2025.6.2.66-74
Abstract
The problem of the high prevalence of risk factors for carbohydrate metabolism disorders does not lose its relevance, while the special role of behavioral risk factors, in particular, eating behavior, is highlighted. Aim. To analyze risk factors for the development of carbohydrate disorders and eating disorders in the population of the Tyumen region. Materials and methods. The study involved 2176 people living in the Tyumen region: 64.8 % (n = 1,411) of women and 35.2 % (n = 765) of men, the median age was 41 (27; 53) years. 43.5 % (n = 947) of respondents lived in the south of the Tyumen region, 40 % (n = 871) – in the Yamalo–Nenets Autonomous District, 16.5 % (n = 358) – in the Khanty-Mansi Autonomous Okrug. Socio-demographic characteristics, behavioral risk factors, symptoms and manifestations of eating disorders were assessed according to the criteria of the DSM-V and the Dutch Eating Behavior Questionnaire (DEBQ), and the risk of developing carbohydrate disorders was assessed according to the FINDRISK scale. Results. Analysis of risk factors for the development of carbohydrate disorders and eating behavior in the population of the Tyumen region, the most common were: a burdened heredity with respect to diabetes mellitus (72.1 %), waist circumference ⩾ 80 cm for women, ⩾ 94 cm for men (43.9 %), age ⩾ 45 years (43.7 %). Eating disorders (bulimia nervosa and compulsive overeating) were detected in 4.7 % of respondents. The presence of verified eating disorders increased the risk of developing carbohydrate disorders by 2.8 times (95 % confidence interval: 1.8–3.2; p = 0.033). Conclusion. Evaluation of the population’s eating behavior, both in terms of identifying disorders and nosological forms, and in terms of pathological patterns of behavior in terms of food intake, can be included in personalized preventive programs for working with the population to increase the effectiveness of verification and prevent the development of carbohydrate d isorders.
About the Authors
D. N. IsakovaRussian Federation
Dilara N. Isakova – Cand. of Sci. (Medicine), Associate Professor, Department of Hospital Therapy with courses in Endocrinology
Odesskaya str., 54, Tyumen, 625023
I. A. Troshina
Russian Federation
Irina A. Troshina – Dr. of Sci. (Medicine), Associate Professor, Head of the Department of Hospital The rapy with courses in Endocrinology
Odesskaya str., 54, Tyumen, 625023
E. A. Evgenуeva
Russian Federation
Elisaveta A. Evgenуeva – Doctor of the therapeutic department, Multidisciplinary Clinic
Odesskaya str., 54, Tyumen, 625023
I. M. Petrov
Russian Federation
Ivan M. Petrov – Dr. of Sci. (Medicine), Head of the Department of Medical Informatics and Biological Physics, Rector
Odesskaya str., 54, Tyumen, 625023
References
1. Magliano D.J., Boyko E.J. IDF Diabetes Atlas 10th edition scientifi c committee. IDF DIABETES ATLAS [Internet]. 10th ed. Brussels: International Diabetes Federation; 2021. PMID: 35914061
2. Wu S., McCormick J.B., Curran J.E., Fisher-Hoch S.P. Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans. Diabetes Metab Syndr Obes. 2017; 10: 491–503. https://doi.org/10.2147/DMSO.S136368. PMID: 29255369
3. Cho N.H., Shaw J.E., Karuranga S., et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2019 and projections for 2030 and 2045. Diabetes Research and Clinical Practice. 2021; 162: 108095. https://doi.org/10.1016/j.diabres.2017.03.024. PMID: 29496507
4. Meressa A., Girma B., Negassa T., et al. Multi-targeted molecular docking, pharmacokinetic analysis, and drug-likeness evaluation of alkaloids for anti-diabetic drug development. The BRICS Health Journal. 2025; 2(1): 53–68. https://doi.org/10.47093/3034-4700.2025.2.1.53-68
5. Teo Z.L., Tham Y.C., Yu M., et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021; 128(11): 1580–1591. https://doi.org/10.1016/j.ophtha.2021.04.027. PMID: 33940045
6. Jonas D.E., Crotty K., Yun J.D.Y., et al. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021; 326(8): 744–760. https://doi.org/10.1001/jama.2021.10403. PMID: 34427595
7. Kobyakova O.S., Kulikov E.S., Malykh R.D., et al. Strategies for the prevention of chronic non-communicable diseases: a modern look at the problem. Cardiovascular Therapy and Prevention. 2019; 18(4): 92–98 (In Russian). https://doi.org/10.15829/1728-8800-2019-4-92-98. EDN: XDSOAT
8. Kärkkäinen U., Mustelin L., Raevuori A., et al. Do Disordered Eating Behaviours Have Long-term Health-related Consequences? Eur Eat Disord Rev. 2018; 26(1): 22–28. https://doi.org/10.1002/erv.2568. PMID: 29160017
9. Dedov I.I., Shestakova M.V., Galstyan G.R. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes Mellitus. 2016; 19(2): 104–112 (In Russian). https://doi.org/10.14341/DM2004116-17. EDN: WBAQHX
10. Shestakova E.A., Lunina E.Yu., Galstyan G.R., et al. Type 2 diabetes and prediabetes prevalence in patients with diff erent risk factor combinations in the NATION study. Diabetes Mellitus. 2020; 23(1): 4–11 (In Russian). https://doi.org/10.14341/DM12286. EDN: DBFKHP
11. Kontsevaya A., Shalnova S., Deev A., et al. Overweight and Obesity in the Russian Population: Prevalence in Adults and Association with Socioeconomic Parameters and Cardiovascular Risk Factors. Obes Facts. 2019; 12(1): 103–114. https://doi.org/10.1159/000493885. PMID: 30844809
12. Ivashkin V.T., Drapkina O.M., Maevskaya M.V., et al. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientifi c Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2025; 35(1): 94–152 (In Russian). https://doi.org/10.22416/1382-4376-2025-35-1-94-152. EDN: HLXIGH
13. Isakova D.N., Petrov I.M., Evgen`eva E.A., et al. Eating disorders: predictors of development in disorders of carbohydrate metabolism. Transbaikalian Medical Bulletin. 2023; 1: 137–148 (In Russian). https://doi.org/10.52485/19986173_2023_1_137. EDN: AETKTT
14. Zelenkova-Zaxarchuk T.A. Eating disorders in patients with obesity and type 2 diabetes mellitus. Lecture for physicians. Consilium Medicum. 2021; 23(4): 326–331 (In Russian). EDN: HQYYAB
15. Nip A.S., Reboussin B.A., Dabelea D., et al. Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2019; 42(5): 859–866. https://doi.org/10.2337/dc18-2420. PMID: 30862656
16. Gendall K.A., Joyce P.R., Carter F.A., et al. The eff ect of bulimia nervosa on plasma glucose and lipids. Physiol Behav. 2002; 77(1): 99–105. https://doi.org/10.1016/s0031- 9384(02)00829-6. PMID: 12213507
17. Yang F., Liu A., Li Y., et al. Food Addiction in Patients with Newly Diagnosed Type 2 Diabetes in Northeast China. Front Endocrinol (Lausanne). 2017; 8: 218. https://doi.org/10.3389/fendo.2017.00218. PMID: 28912753
18. Starostina E.G., Ananyan M.V. Binge eating disorder: epidemiological, clinical, pathophysiological, and treatment aspects. Diabetes Mellitus. 2024; 27(1): 81–92 (In Russian). https://doi.org/10.14341/DM13122. EDN: CUHSQX
Review
For citations:
Isakova D.N., Troshina I.A., Evgenуeva E.A., Petrov I.M. Analysis of risk factors for carbohydrate metabolism disorders in the population of the Tyumen region. National Health Care (Russia). 2025;6(2):66-74. (In Russ.) https://doi.org/10.47093/2713-069X.2025.6.2.66-74